HighMark Wealth Management’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

HighMark Wealth Management’s Portfolio GMVD Stock Details GMVD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-47	Closed	-$18	–	588
2023 Q2	$18	Hold	47	–	–	﹤0.01%	561
2023 Q1	$43	Hold	47	–	–	﹤0.01%	598
2022 Q4	$154	Hold	47	–	–	﹤0.01%	521
2022 Q3	$0	Hold	47	–	–	﹤0.01%	566
2022 Q2	$1K	Hold	47	–	–	﹤0.01%	507
2022 Q1	$2K	Buy	+47	New	+$4.6K	﹤0.01%	465

Other funds holding GMVD

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

HighMark Wealth Management's GMVD Position: Q3 2023 in Review

HighMark Wealth Management sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q3 2023, closing a stake of 47 shares — an estimated $18 sold.

HighMark Wealth Management first reported a position in GMVD in Q1 2022 and held it in 6 quarters. The position peaked at $2K in Q1 2022. 3 funds tracked by Wall St. Rank hold GMVD as of Q3 2023.

HighMark Wealth Management reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q3 2023 after selling out during the quarter.
HighMark Wealth Management sold 47 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q3 2023, an estimated $18.
HighMark Wealth Management first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q1 2022 and held it in 6 quarters.
HighMark Wealth Management's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $2K in Q1 2022.
3 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q3 2023.

Based on HighMark Wealth Management's 13F filing for Q3 2023, filed 18 Oct 2023.